Letter by Jin-shan and Xue-bin Regarding Article, “coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve after Treatment in a Prospective Observational Study”
Jing He,Xuebin Li
DOI: https://doi.org/10.1161/circulationaha.117.031391
IF: 37.8
2018-01-01
Circulation
Abstract:HomeCirculationVol. 137, No. 10Letter by Jin-shan and Xue-bin Regarding Article, “Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study” Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBLetter by Jin-shan and Xue-bin Regarding Article, “Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study” He Jin-shan, MD and Li Xue-bin, MD He Jin-shanHe Jin-shan Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People’s Hospital, Beijing, China. Search for more papers by this author and Li Xue-binLi Xue-bin Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People’s Hospital, Beijing, China. Search for more papers by this author Originally published6 Mar 2018https://doi.org/10.1161/CIRCULATIONAHA.117.031391Circulation. 2018;137:1089To the Editor:We read with great interest the article presented by Joseph B. Lerman and his colleagues1 about the coronary plaque characterization in psoriasis, which indicates that patients with psoriasis had a greater noncalcified coronary plaque burden and increased high-risk plaque prevalence than healthy volunteers, and the plaque conditions can improve after 1 year of treatment with inflammation modulation. We have several questions about this article. First, psoriasis is strongly associated with multiple comorbidities, including obesity, tobacco smoking, diabetes mellitus, dyslipidemia, and hypertension,2 most of which are also risk factors of coronary artery atherosclerosis. What is the real reason for high-risk plaque forming in psoriasis? What is the common effect of multiple atherosclerosis risk factors or psoriasis itself? Second, this article indicates that modulation of target skin inflammation is associated with an improvement in noncalcified coronary plaque burden at 1 year, suggesting that the control of remote sites of inflammation may translate into reduced coronary artery disease risk. Do we need more study to validate this result, so that we can evaluate the coronary artery plaque conditions by skin lesions instead of other invasive or expensive methods? Third, psoriasis and atherosclerosis share several proinflammatory cytokines in their pathophysiology, such as myocyte chemoattractant protein–1, tumor necrosis factor–α, and interleukin-1β. What is their exact effect in plaque formation? Can they be used as the target of treatment to reduce coronary artery risk in patients with psoriasis? Can we evaluate the treatment effect by detecting their level in blood? We are hoping for more research to elevate and elucidate our understanding of the associations of psoriasis and cardiovascular disease.DisclosuresNone.Footnoteshttp://circ.ahajournals.orgReferences1. Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, Salahuddin T, Chung JH, Rana A, Teague HL, Wu JJ, Playford MP, Lockshin BA, Chen MY, Sandfort V, Bluemke DA, Mehta NN. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study.Circulation. 2017; 136:263–276. doi: 10.1161/CIRCULATIONAHA.116.026859.LinkGoogle Scholar2. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: epidemiology.J Am Acad Dermatol. 2017; 76:377–390. doi: 10.1016/j.jaad.2016.07.064.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails March 6, 2018Vol 137, Issue 10 Advertisement Article InformationMetrics © 2018 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.117.031391PMID: 29507001 Originally publishedMarch 6, 2018 PDF download Advertisement SubjectsCardiovascular DiseaseInflammation